Company Filing History:
Years Active: 1997-2000
Title: Rein Strijker: Innovator in Recombinant Polypeptide Production
Introduction
Rein Strijker is a notable inventor based in Oegstgeest, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant polypeptides using transgenic bovine species. With a total of seven patents to his name, Strijker's work has the potential to impact various industries, including pharmaceuticals and food production.
Latest Patents
Strijker's latest patents focus on the production of recombinant polypeptides by bovine species. One of his key inventions involves transgenes designed for producing recombinant polypeptides in the milk of transgenic bovine species. These transgenes include essential components such as expression regulation sequences, secretory DNA sequences, and recombinant DNA sequences that encode the desired polypeptides. The methods outlined in his patents detail the process of introducing these transgenes into embryonal target cells of bovine species, leading to the development of transgenic offspring capable of producing recombinant polypeptides in their milk. This innovative approach not only enhances the efficiency of polypeptide production but also opens avenues for creating food formulations that incorporate these valuable proteins.
Career Highlights
Throughout his career, Rein Strijker has worked with prominent companies in the biotechnology sector, including Pharming B.V. and Genpharm International, Inc. His expertise in genetic engineering and transgenic technology has positioned him as a leader in his field. Strijker's contributions have been instrumental in advancing the understanding and application of recombinant DNA technology.
Collaborations
Strijker has collaborated with notable professionals in the industry, including Frank R. Pieper and Paul J. Krimpenfort. These collaborations have further enriched his research and development efforts, leading to innovative solutions in biotechnology.
Conclusion
Rein Strijker's work in the field of recombinant polypeptide production exemplifies the intersection of innovation and biotechnology. His patents and career achievements highlight the importance of transgenic technology in addressing modern challenges in health and nutrition.